ReidJRobisonMDMBA
Psychiatry • Orem, UTChild & Adolescent Psychiatry, Psychopharmacology, Integrative Psychiatry
Psychiatrist at DoctorReid.com, a public benefit organization). Principal Investigator at Cedar Clinical Research. Medical Director at Center for Change. Co-founded Cedar Psychiatry, acquired by Numinus. Co-founded Tute Genomics and Anolinx, both acquired. Adjunct Faculty at University of Utah and BYU. Founded Polizzi Free Clinic and Psychedelic Institute.
Dr. Robison is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1788 N State St
Orem, UT 84057Phone+1 801-839-5227
Summary
- Dr. Reid Robison is a psychiatrist in Orem, UT, Principal Investigator at Numinus, and Medical Director at Center for Change. He received his medical degree from University of Utah School of Medicine. He specializes in psychopharmacology, treatment-resistant conditions, eating disorders & psychedelic medicine. He has dozens publications, hundreds of citations, and has led over 250 clinical trials.
Education & Training
Unviersity of Utah Department of Biomedical InformaticsPost doc, Bioinformatics, NLM Fellow, 2009 - 2010- University of Utah CTSAFellowship, 2008 - 2009
University of Utah HealthResidency, Psychiatry, 2005 - 2009- University of Utah HealthInternship, Psychiatry, 2005 - 2006
- University of Utah Eccles School of BusinessMBA, Business, 2002 - 2005
University of Utah School of MedicineClass of 2005
Certifications & Licensure
UT State Medical License 2006 - 2026
AZ State Medical License 2023 - 2025
CO State Medical License 2023 - 2025
NV State Medical License 2023 - 2025
WI State Medical License 2023 - 2025
WY State Medical License 2023 - 2025
ID State Medical License 2007 - 2024- American Board of Psychiatry and Neurology Psychiatry
- Join now to see all
Awards, Honors, & Recognition
- Fellow American Psychiatric Association, 2024
Clinical Trials
- Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults Start of enrollment: 2023 Jan 31
- Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD Start of enrollment: 2023 Jan 19
- Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD) Start of enrollment: 2022 May 06
- Join now to see all
Publications & Presentations
PubMed
- 111 citationsSingle-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.Charles L Raison, Gerard Sanacora, Joshua Woolley, Keith Heinzerling, Boadie W Dunlop
JAMA. 2023-09-05 - 1 citationsKetamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants.Reid Robison, Madeline Brendle, Claire Moore, Hannah Cross, Lindsay Helm
Journal of Psychoactive Drugs. 2023-03-02 - 8 citationsBreathwork Interventions for Adults with Clinically Diagnosed Anxiety Disorders: A Scoping Review.Blerida Banushi, Madeline Brendle, Anya Ragnhildstveit, Tara Murphy, Claire Moore
Brain Sciences. 2023-02-02
Press Mentions
Mind Medicine MindMed : Q2 2024 Earnings Call PresentationAugust 14th, 2024- Mind Medicine MindMed : Investor Presentation - Q2 2024 Earnings Call PresentationAugust 13th, 2024
- MindMed Gets Breakthrough Designation for LSD Candidate in AnxietyMarch 15th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
